Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 12.43T | 10.89T | 4.00T | 5.25T | 5.33T |
Gross Profit | 7.03T | 5.38T | 4.00T | 4.37T | 4.04T |
EBITDA | 2.97T | 2.41T | 1.90T | 1.85T | 1.40T |
Net Income | 1.86T | 1.49T | 1.12T | 1.13T | 777.02B |
Balance Sheet | |||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Total Debt | 89.40T | 25.75T | 47.28T | 19.11T | 18.09T |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 20.52T | 19.59T | 17.23T | 17.02T | 16.80T |
Cash Flow | |||||
Free Cash Flow | -450.29B | -10.31T | 13.03T | 9.25T | 34.51T |
Operating Cash Flow | 6.42B | -9.84T | 13.43T | 9.64T | 34.90T |
Investing Cash Flow | -186.95B | -1.27T | -10.68T | -2.20T | -10.14T |
Financing Cash Flow | -861.12B | 8.31B | -977.14B | -875.97B | -436.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $212.07B | 11.24 | 10.83% | 3.25% | -1.91% | -6.79% | |
78 Outperform | $123.17B | 8.87 | 13.25% | 3.01% | 0.26% | 19.35% | |
77 Outperform | $97.85B | 12.81 | 7.92% | 2.50% | 0.23% | 18.12% | |
76 Outperform | $156.11B | 13.23 | 9.18% | 1.93% | 5.39% | 20.82% | |
76 Outperform | $157.60B | 13.33 | 6.30% | 2.65% | 2.97% | 87.82% | |
76 Outperform | $258.71B | 14.28 | 11.05% | 2.01% | 3.51% | 16.51% | |
67 Neutral | $16.67B | 11.46 | 9.71% | 3.91% | 11.61% | -9.60% |